My hunch is that if MPL is proven to be the best available treatment for MND, and there is every reason at the moment to believe that is where it is heading, then PAA will get bought out by BP with the option for BP to continue to investigate success of MPL on other indications, on the back off existing data, being the sweetener for the business case for such acquisition.
My hunch is that if MPL is proven to be the best available...
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $111.9M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $289.4K | 1.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 149248 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 6664 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |